Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis

Hepatology. 2023 Jun 1;77(6):E174-E175. doi: 10.1097/HEP.0000000000000304. Epub 2023 Jan 30.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cholangitis, Sclerosing* / drug therapy
  • Humans
  • Insurance*
  • Vancomycin / therapeutic use

Substances

  • Vancomycin
  • Anti-Bacterial Agents